These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8877867)

  • 1. Development of chiral high performance liquid chromatographic assays for the enantiomers of 8-hydroxy-(di-n-propylamino)tetralin and three 8-keto-pyrrole-substituted analogues.
    Wood SA; Pegg SN; Simmonds RJ; Stevenson D
    J Pharm Biomed Anal; 1996 Aug; 14(11):1591-9. PubMed ID: 8877867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective metabolism of two keto-pyrrol analogues of 8-hydroxy-2-dipropyl-aminotetralin by freshly isolated rat hepatocytes.
    Wood SA; Parton AH; Simmonds RJ; Stevenson D
    Chirality; 1996; 8(3):264-70. PubMed ID: 8777147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of U-89968E, a 5HT1a agonist in rat plasma using solid-phase extraction, precolumn derivatization and reversed-phase high-performance liquid chromatography.
    Rees SA; Austin PM
    J Pharm Biomed Anal; 1997 Mar; 15(6):739-48. PubMed ID: 9172099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
    J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW; Mefford IN; Smith CC; Gold PW; Sternberg EM
    J Neurochem; 1992 Sep; 59(3):1062-70. PubMed ID: 1379629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a chiral liquid chromatographic method, based on Chiralpak to quantify enantiomers of (+/-)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(-)-DRF 2725) to its antipode in plasma.
    Mustafa SS; Trivedi R; Mamidi NV; Mullangi R; Srinivas NR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):23-30. PubMed ID: 15282089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 14. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA; Titeler M; Lyon RA; Slusher RM
    J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
    Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
    J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in high-performance liquid chromatographic analysis of small molecules. Application of high-performance liquid chromatography with electrochemical detection to the study of neurotransmitters in vivo.
    Routledge C; Marsden CA
    Biochem Soc Trans; 1985 Dec; 13(6):1058-61. PubMed ID: 2419180
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Liu Y; Hacksell U; Lewander T
    J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopaminergic activity of pyridine analogs of 5-hydroxy-2-(di-n-propylamino)tetralin.
    Glase SA; Corbin AE; Pugsley TA; Heffner TG; Wise LD
    J Med Chem; 1995 Aug; 38(16):3132-7. PubMed ID: 7636875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the enantiomers of a novel 20,21-dinoreburnamenine derivative in rat plasma and brain by high-performance liquid chromatography using a chiral stationary phase.
    Vicat P; Cousty-Berlin D; Hunt P
    J Chromatogr; 1992 Mar; 575(2):315-8. PubMed ID: 1629312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.